Eur Radiol. 2014 Mar;24(3):603-9. doi: 10.1007/s00330-013-3029-1.
To investigate the diagnostic value of 3-Tesla (T) breast MRI in patients presenting with microcalcifications on mammography.
Between January 2006 and May 2009, 123 patients with mammographically detected BI-RADS 3–5 microcalcifications underwent 3-T breast MRI before undergoing breast biopsy. All MRIs of the histopathologically confirmed index lesions were reviewed by two breast radiologists. The detection rate of invasive carcinoma and ductal carcinoma in situ (DCIS) was evaluated, as well as the added diagnostic value of MRI over mammography and breast ultrasound.
At pathology, 40/123 (33%) lesions proved malignant; 28 (70%) DCIS and 12 (30%) invasive carcinoma. Both observers detected all invasive malignancies at MRI, as well as 79% (observer 1) and 86% (observer 2) of in situ lesions. MRI in addition to conventional imaging led to a significant increase in area under the receiver operating characteristic (ROC) curve from 0.67 (95% CI 0.56–0.79) to 0.79 (95% CI 0.70–0.88, observer 1) and to 0.80 (95% CI 0.71–0.89, observer 2), respectively.
3-T breast MRI was shown to add significant value to conventional imaging in patients presenting with suspicious microcalcifications on mammography.
• 3-T MRI is increasingly used for breast imaging in clinical practice. • On 3-T breast MRI up to 86% of DCIS lesions are detected. • 3-T MRI increases the diagnostic value in patients with mammographically detected microcalcifications.
探讨磁共振成像(MRI)在乳腺钼靶微钙化患者中的诊断价值。
2006 年 1 月至 2009 年 5 月,123 例乳腺钼靶 BI-RADS 3-5 级微钙化患者行 3T 乳腺 MRI 检查,随后进行活检。由两位乳腺放射科医生对所有经组织病理学证实的病灶 MRI 进行回顾性分析。评估 MRI 对浸润性癌和导管原位癌(DCIS)的检出率,并评估 MRI 相对于乳腺钼靶和超声的附加诊断价值。
病理证实 123 例病灶中 40 例为恶性(33%);28 例 DCIS(70%)和 12 例浸润性癌(30%)。两位观察者均在 MRI 上检测到所有浸润性恶性肿瘤,同时分别在观察者 1 和观察者 2 上检测到 79%和 86%的原位病变。与传统影像学相比,MRI 可显著提高观察者 1 和观察者 2 的 ROC 曲线下面积,分别从 0.67(95%CI 0.56-0.79)提高到 0.79(95%CI 0.70-0.88)和 0.80(95%CI 0.71-0.89)。
3T 乳腺 MRI 在乳腺钼靶可疑微钙化患者的常规成像中具有显著的附加价值。
3-T MRI 在临床实践中越来越多地用于乳腺成像。
在 3-T 乳腺 MRI 上,多达 86%的 DCIS 病变可被检出。
3-T MRI 增加了乳腺钼靶微钙化患者的诊断价值。